Obiettivo
NAMDIATREAM will develop a cutting edge nanotechnology-based toolkit for multi-modal detection of biomarkers of most common cancer types and cancer metastases, permitting identification of cells indicative of early disease onset in a high-specificity and throughput format in clinical, laboratory and point-of-care devices. The project is built on the innovative concepts of super-sensitive and highly specific “lab-on-a-bead”, “lab-on-a-chip” and “lab-on-a-wire” nano-devices utilizing photoluminescent, plasmonic, magnetic and non-linear optical properties of nanomaterials. This offers groundbreaking advantages over present technologies in terms of stability, sensitivity, time of analysis, probe multiplexing, assay miniaturisation and reproducibility. The ETP in Nanomedicine documents point out that nanotechnology has yet to deliver practical solutions for the patients and clinicians in their struggle against common, socially and economically important diseases such as cancer. Over 3.2M new cases and 1.7M cancer-related deaths are registered in Europe every year, largely because diagnostic methods have an insufficient level of sensitivity, limiting their potential for early disease identification. We will deliver •Photoluminescent nanoparticle-based reagents and diagnostic chips for high throughput early diagnosis of cancer and treatment efficiency assessment •Nanocrystals enabling plasmon-optical and nonlinear optical monitoring of molecular receptors within body fluids or on the surface of cancer cell •Multi-Parameter screening of cancer biomarkers in diagnostic material implementing segmented magnetic nanowires •Validation of nano-tools for early diagnosis and highly improved specificity in cancer research. •OECD-compliant nanomaterials with improved stability, signal strength and biocompatibility Direct lead users of the results will be the diagnostic and medical imaging device companies involved in the consortium, clinical and academic partners
Campo scientifico
- engineering and technologyother engineering and technologiesmicrotechnologylab on a chip
- medical and health sciencesmedical biotechnologynanomedicine
- engineering and technologynanotechnologynano-materialsnanocrystals
- medical and health sciencesclinical medicineoncology
- engineering and technologymedical engineeringdiagnostic imaging
Programma(i)
Argomento(i)
Invito a presentare proposte
FP7-NMP-2009-LARGE-3
Vedi altri progetti per questo bando
Meccanismo di finanziamento
CP-IP - Large-scale integrating projectCoordinatore
D02 CX56 DUBLIN 2
Irlanda
Mostra sulla mappa
Partecipanti (22)
Partecipazione conclusa
20018 San Sebastian
Mostra sulla mappa
1210 Wien
Mostra sulla mappa
1211 Geneve
Mostra sulla mappa
35037 Marburg
Mostra sulla mappa
4 Dublin
Mostra sulla mappa
75654 Paris
Mostra sulla mappa
31077 TOULOUSE CEDEX 4
Mostra sulla mappa
38106 Braunschweig
Mostra sulla mappa
1015 Lausanne
Mostra sulla mappa
73011 Chambery
Mostra sulla mappa
80539 Munchen
Mostra sulla mappa
38800 Le Pont De Claix
Mostra sulla mappa
94504 CHAMPIGNY SUR MARNE CEDEX
Mostra sulla mappa
48160 VIZCAYA BIZKAIA
Mostra sulla mappa
00131 Roma
Mostra sulla mappa
D12 EK79 Dublin
Mostra sulla mappa
NE2 4HH Newcastle upon Tyne
Mostra sulla mappa
SP4 7RT WILTSHIRE
Mostra sulla mappa
IP31 HF29 Cork
Mostra sulla mappa
01630 Saint Genis Pouilly
Mostra sulla mappa
55716 IDAR OBERSTEIN
Mostra sulla mappa
51100 Reims
Mostra sulla mappa